Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

Testosterone plays a critical role in male sexual functioning but can also impact bone mass, fat distribution, muscle mass, ...

For postmenopausal women with overweight or obesity receiving tirzepatide, menopausal hormone therapy linked to increased weight loss.

Benefits were most prominent among women, patients older than 60 and those with a body mass index of 30 to 40.

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...

Research from ENDO 2025 reveals that GLP-1 anti-obesity medications not only aid in weight loss but also improve testosterone ...

The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...

A new study found weight loss injections may help reduce the risk of dementia and stroke in people who are obese and have ...